Charles Schwab Portfolio holdings
Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$304M |
| 2 |
iShares 1-3 Year Treasury Bond ETF
SHY
|
+$189M |
| 3 |
AbbVie
ABBV
|
+$185M |
| 4 |
JPMorgan Ultra-Short Income ETF
JPST
|
+$176M |
| 5 |
iShares US Treasury Bond ETF
GOVT
|
+$174M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$430M |
| 2 |
Vanguard High Dividend Yield ETF
VYM
|
+$400M |
| 3 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$374M |
| 4 |
iShares 0-1 Year Treasury Bond ETF
SHV
|
+$361M |
| 5 |
Invesco Actively Managed Exch-Traded Commodity Fd Tr Invesco Optimum Yield Diversified Commodity Strategy No K-1 ETF
PDBC
|
+$154M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.95% |
| 2 | Healthcare | 12.56% |
| 3 | Financials | 11.62% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Industrials | 9.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
nLIGHT
LASR
$3.88B
| $5.22M | ﹤0.01% |
338,822
+792
| +0.2% | +$9.68K |
|
|
PLYA
2227
DELISTED
Playa Hotels & Resorts
PLYA
| $5.19M | ﹤0.01% |
637,415
-39,984
| -6% | -$363K |
|
2228
GoPro
GPRO
$130M
| $5.17M | ﹤0.01% |
1,249,731
+178,930
| +17% | +$767K |
|
2229
Vita Coco
COCO
$3.82B
| $5.12M | ﹤0.01% |
190,657
+2,965
| +2% | +$72.2K |
|
2230
Arcturus Therapeutics
ARCT
$164M
| $5.12M | ﹤0.01% |
178,506
-870
| -0.5% | -$23.7K |
|
2231
QCR Holdings
QCRH
$1.69B
| $5.1M | ﹤0.01% |
124,295
+1,537
| +1% | +$62.9K |
|
|
KE
2232
Kimball Electronics
KE
$595M
| $5.09M | ﹤0.01% |
184,361
+1,639
| +0.9% | +$38.8K |
|
|
DX
2233
Dynex Capital
DX
$3.15B
| $5.08M | ﹤0.01% |
403,469
+6,887
| +2% | +$80.5K |
|
|
NKLA
2234
DELISTED
Nikola Corporation Common Stock
NKLA
| $5.06M | ﹤0.01% |
122,165
+33,707
| +38% | +$930K |
|
2235
Revolve Group
RVLV
$1.8B
| $5.06M | ﹤0.01% |
308,364
-6,026
| -2% | -$112K |
|
2236
Kura Oncology
KURA
$800M
| $5.05M | ﹤0.01% |
477,280
+6,289
| +1% | +$74.4K |
|
2237
Mesa Laboratories
MLAB
$564M
| $4.98M | ﹤0.01% |
38,787
+254
| +0.7% | +$38.7K |
|
2238
Covenant Logistics
CVLG
$894M
| $4.97M | ﹤0.01% |
226,966
-37,640
| -14% | -$727K |
|
|
DSEY
2239
DELISTED
Diversey Holdings, Ltd. Ordinary Shares
DSEY
| $4.92M | ﹤0.01% |
586,834
+8,627
| +1% | +$71.2K |
|
2240
Xometry
XMTR
$4.74B
| $4.91M | ﹤0.01% |
231,754
+3,277
| +1% | +$57.3K |
|
|
BIG
2241
DELISTED
Big Lots, Inc.
BIG
| $4.91M | ﹤0.01% |
555,685
+94,826
| +21% | +$804K |
|
2242
Novavax
NVAX
$1.2B
| $4.84M | ﹤0.01% |
652,076
+196,492
| +43% | +$1.55M |
|
2243
Lufax Holding
LU
$1.35B
| $4.83M | ﹤0.01% |
845,025
+182,340
| +28% | +$1.21M |
|
|
VMEO
2244
DELISTED
Vimeo
VMEO
| $4.82M | ﹤0.01% |
1,169,641
+24,235
| +2% | +$91.8K |
|
|
ONL
2245
Orion Office REIT
ONL
$150M
| $4.82M | ﹤0.01% |
728,515
+22,363
| +3% | +$139K |
|
2246
4D Molecular Therapeutics
FDMT
$532M
| $4.81M | ﹤0.01% |
266,077
+47,971
| +22% | +$883K |
|
2247
Seadrill
SDRL
$2.8B
| $4.8M | ﹤0.01% |
+116,311
| New | +$4.32M |
|
2248
Banc of California
BANC
$3.03B
| $4.79M | ﹤0.01% |
413,909
+8,281
| +2% | +$95.6K |
|
|
AMK
2249
DELISTED
AssetMark Financial Holdings, Inc.
AMK
| $4.79M | ﹤0.01% |
161,495
+2,556
| +2% | +$75.1K |
|
2250
Teva Pharmaceuticals
TEVA
$40.8B
| $4.77M | ﹤0.01% |
633,976
+21,741
| +4% | +$176K |
|
Similar funds
Charles Schwab's Q2 2023 Portfolio in Review
As of Q2 2023, Charles Schwab held 3,760 positions worth $350B, up 6.4% from $329B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Charles Schwab's Q2 2023 filing shows 210 new, 2,215 increased, 1,001 reduced and 151 closed positions. Its largest new stake was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M. The largest sale was Broadcom, an estimated $430M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
- Charles Schwab's largest Q2 2023 buy was iShares US Treasury Bond ETF: 7,510,883 shares worth $172M.
- Charles Schwab added most to State Street Technology Select Sector SPDR ETF in Q2 2023, an estimated $304M increase.
- Charles Schwab's biggest Q2 2023 reduction was Broadcom, cutting an estimated $430M.
- Charles Schwab fully exited iShares 0-1 Year Treasury Bond ETF in Q2 2023, selling an estimated $361M.
- Charles Schwab's ten largest holdings make up 19% of its $350B portfolio in Q2 2023.
- Charles Schwab opened 210 new positions and closed 151 in Q2 2023.
- Charles Schwab's portfolio value rose 6.4% quarter-over-quarter to $350B.
Based on Charles Schwab's 13F filing for Q2 2023, filed 10 Aug 2023.